Antiinflammatory activity of the platelet-activating factor receptor antagonist A-85783

Archives of Dermatological Research

Volumn 290, Issue 10, 1998, Pages 569-573

  Travers, J ^a,b   Pei, Y ^a   Morin, S M ^a   Hood, A F ^a  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dermatitis; Phorbol myristic acetate; Platelet activating factor; Platelet activating factor receptor; Skin

Indexed keywords

6 (4 FLUOROPHENYL) 3 [3 (3 PYRIDYL) 1H,3H PYRROLO[1,2 C]THIAZOL 7 YL] 1 INDOLECARBOXYLIC ACID DIMETHYLAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; EXTERNAL EAR; INTRADERMAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN INFLAMMATION; TOPICAL DRUG ADMINISTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; EAR; INDOLES; INFLAMMATION; MALE; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SKIN; THIAZOLES;

EID: 0031725804     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050353     Document Type: Article

References (22)

1. Prescott SM, Zimmerman GA, McIntyre TM (1990) Platelet-activating factor. J Biol Chem 265:17381-17384
2. Izumi T, Shimizu T (1995) Platelet-activating factor receptor: gene regulation and signal transduction. Biochim Biophys Acta 1259:317-333
3. Summers JB, Albert DH (1995) Platelet-activating factor antagonists. Adv Pharmacol 32:67-168
4. Michel L, Dubertret L (1992) Leukotriene and platelet-activating factor in human skin. Arch Dermatol Res 284:s12-17
5. Michel L, Denizot Y, Thomas Y, Jean-Louis F, Heslan M, Benveniste J, Dubertret L (1990) Production of paf-acether by human epidermal cells. J Invest Dermatol 95:576-581
6. Travers JB, Harrison KA, Johnson CA, Clay KL, Morelli JG, Murphy RC (1996) Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes. J Invest Dermatol 107:88-94
7. Mallet AI, Cunningham FM (1985) Structural identification of platelet-activating factor in psoriatic scale. Biochem Biophys Res Commun 126:192-196
8. Grandel KE, Farr RS, Wanderer AA, Eisenstadt TC, Wassermann SI (1985) Association of platelet-activating factor with primary acquired cold urticaria. New Engl J Med 313:405-409
9. Travers JB, Huff JC, Rola-Pleszczynski M, Gelfand EW, Morelli JG, Murphy RC (1995) Identification of functional platelet-activating factor receptors on human keratinocytes. J Invest Dermatol 105:816-823
10. Archer CB, Page CP, Morley JP, MacDonald DM (1984) Inflammatory characteristics of platelet-activating factor (Pafacether) in human skin. Br J Dermatol 110:45-49
11. Hellewell PG, Williams TJ (1989) Antagonism of PAF-induced oedema formation in rabbit skin: a comparison of different antagonists. Br J Pharmacol 97(1):171-180
12. Michel L, Mencia-Huerta JM, Benveniste J, Dubertret L (1987) Biological properties of LTB4 and PAF-acether in vivo in human skin. J Invest Dermatol 88(6):675-681
13. Albert DH, Conway RG, Magoc TJ, Tapang P, Rhein DA, Luo G, Holms JH, Davidsen SK, Summers JB, Carter GW (1996) Properties of ABT-299, a pro-drug of A-85783, a highly potent platelet-activating factor receptor antagonist. J Pharmacol Exp Thera 277(3):1595-1606
14. Ishii S, Nagase T, Tashiro F, Ikuta K, Sato S, Waga I, Kume K, Miyaazaki J, Shimizu T (1997) Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J 16:133-142
15. Chung KF, Dent G, McCusker M, Guinot P, Page CP, Barnes PJ (1987) Effect of a ginkolide mixture (BN 52063) in antagonizing skin and platelet responses to platelet-activating factor in man. Lancet 1(8527):248-251
16. Sheppard GS, Pireh D, Carrera G, Bures M, Heyman HR, Steinman D, Davidsen SK, Phillips J, Guinn DE, May PD, Conway RG, Rhein DA, Calhoun WC, Albert DH, Magoc TJ, Carter GW, Summers JB (1994) 3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet-activatina factor antagonists. J Med Chem 37:2011-2032
17. Church DJ, Braconi S, Vallotton MB, Lung V (1993) Protein kinase C-mediated phospholipase A2 activity, platelet-activating factor generation and prostacyclin release in spontaneously beating rat cardiomyocytes. Biochem J 290:477-482
18. Kemeny L, Trach V, Dobozy A (1996) Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice. Arch Dermatol Res 288:492-494
19. Merlos M, Gomez LA, Giral M, Venicot ML, Garcia-Rafanell J Forn J (1991) Effects of platelet-activating factor antagonists in mouse ear oedema induced by several inflammatory agents. Br J Pharmacol 104:990-994
20. Csato M, Csarnetzki BM (1988) Effect of BN52021, a platelet-activating factor antagonist, on experimental murine contact dermatitis. Br J Dermatol 118:475-480
21. Roth M, Nauck M, Yousefi S, Tamm M, Blaser K, Perruchoud AP, Simon H (1996) Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J Exp Med 184:191-198
22. Sanz MJ, Weg VB, Bolanowski MA, Nourshargh S (1995) Interleukin 1 is a potent inducer of eosinophil accumulation in rat skin. Inhibition of response by a platelet-activating factor antagonist and anti-human interleukin 8 antibody. J Immunol 154: 1364-1373